Compounds of Formula I have activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4 and are useful for treating disease whose symptoms and or damage are related to the binding of VCAM-1 to cells expressing VLA-4.
公式I的化合物具有抑制VCAM-1与表达V
LA-4的细胞之间结合的活性,并且可用于治疗与VCAM-1与表达V
LA-4的细胞之间结合有关的症状和/或损伤的疾病。